SAN FRANCISCO, CA — The Gladstone Institutes and the
international pharmaceutical company H. Lundbeck A / S have announced a collaborative
research agreement to study and identify therapeutic candidates for
neurological diseases.
Widely recognized for his conceptual model, clinical work, and
research with families facing serious physical disorders, including
neurological conditions, he is a frequent presenter at national and
international conferences and has published over 70 scholarly papers.